Priovant Therapeutics
Developing novel autoimmune therapies
- B2C
About Priovant Therapeutics
Clinical-stage biotech company developing novel therapies for severe autoimmune diseases by targeting specific molecular dysregulations to provide new treatment options for underserved patients
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- durham, north carolina, United States
- Revenue
- $23.7M – $187MTamtam estimate
- Website
- priovant.com
Priovant Therapeutics at a glance
Priovant Therapeutics is a B2C company in the Biotechnology Research industry, headquartered in durham, north carolina, United States.
Priovant Therapeutics has 51–250 employees.
Priovant Therapeutics's revenue is $23.7M – $187M (Tamtam estimate).
Selling to companies like Priovant Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies